Literature DB >> 18762588

Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder.

Matthew J Kempton1, John R Geddes, Ulrich Ettinger, Steven C R Williams, Paul M Grasby.   

Abstract

CONTEXT: Despite 25 years of structural imaging in bipolar disorder, brain regions affected in the disorder are ill defined.
OBJECTIVES: To use meta-analytical techniques to investigate structural brain changes in bipolar disorder and to assess the effect of medication use and demographic and clinical variables. DATA SOURCES: The MEDLINE, EMBASE, and PsycINFO databases were searched from 1980-2007 for studies using magnetic resonance imaging or x-ray computed tomography to compare brain structure in patients with bipolar disorder and controls. STUDY SELECTION: We identified 1471 unique publications from which 141 studies were included in a database and 98 were selected for meta-analysis. DATA EXTRACTION: Twenty-six demographic and clinical variables were extracted from each study where available. For the meta-analysis, mean structure size and standard deviation were extracted for continuous variables, and numbers of patients and controls with an abnormality were extracted for binary variables. DATA SYNTHESIS: Bipolar disorder was associated with lateral ventricle enlargement (effect size = 0.39; 95% confidence interval, 0.24-0.55; P = 8 x 10(-7)) and increased rates of deep white matter hyperintensities (odds ratio = 2.49; 95% confidence interval, 1.64-3.79; P = 2 x 10(-5)) but not periventricular hyperintensities. Gray matter volume increased among patients when the proportion of patients using lithium increased (P = .004). Calculations from this meta-analysis show current imaging studies (which typically examine 8 regions) have a 34% chance of making a type I error. Type II errors are also appreciable (for example, 70% when measuring the lateral ventricular volume in a typical study involving 25 patients and 33 controls).
CONCLUSIONS: The meta-analyses revealed robust but regionally nonspecific changes of brain structure in bipolar disorder. Individual studies will remain underpowered unless sample size is increased or improvements in phenotypic selection and imaging methods are made to reduce within-study heterogeneity. The provision of online databases, as illustrated herein, may facilitate a more refined design and analysis of structural imaging data sets in bipolar disorder.

Entities:  

Mesh:

Year:  2008        PMID: 18762588     DOI: 10.1001/archpsyc.65.9.1017

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  141 in total

1.  Lithium monotherapy associated clinical improvement effects on amygdala-ventromedial prefrontal cortex resting state connectivity in bipolar disorder.

Authors:  Murat Altinay; Harish Karne; Amit Anand
Journal:  J Affect Disord       Date:  2017-06-27       Impact factor: 4.839

2.  Multicenter study of brain volume abnormalities in children and adolescent-onset psychosis.

Authors:  Santiago Reig; Mara Parellada; Josefina Castro-Fornieles; Joost Janssen; Dolores Moreno; Inmaculada Baeza; Nuria Bargalló; Ana González-Pinto; Montserrat Graell; Felipe Ortuño; Soraya Otero; Celso Arango; Manuel Desco
Journal:  Schizophr Bull       Date:  2010-05-16       Impact factor: 9.306

3.  Auditory steady state response in bipolar disorder: relation to clinical state, cognitive performance, medication status, and substance disorders.

Authors:  Olga Rass; Giri Krishnan; Colleen A Brenner; William P Hetrick; Colleen C Merrill; Anantha Shekhar; Brian F O'Donnell
Journal:  Bipolar Disord       Date:  2010-12       Impact factor: 6.744

Review 4.  Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments.

Authors:  George Bartzokis
Journal:  Neuropharmacology       Date:  2012-01-28       Impact factor: 5.250

5.  A comprehensive testing protocol for MRI neuroanatomical segmentation techniques: Evaluation of a novel lateral ventricle segmentation method.

Authors:  Matthew J Kempton; Tracy S A Underwood; Simon Brunton; Floris Stylios; Anne Schmechtig; Ulrich Ettinger; Marcus S Smith; Simon Lovestone; William R Crum; Sophia Frangou; Steven C R Williams; Andrew Simmons
Journal:  Neuroimage       Date:  2011-07-30       Impact factor: 6.556

Review 6.  Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: developing treatments using an integrated translational approach.

Authors:  Rodrigo Machado-Vieira; Marcio G Soeiro-De-Souza; Erica M Richards; Antonio L Teixeira; Carlos A Zarate
Journal:  World J Biol Psychiatry       Date:  2013-09-02       Impact factor: 4.132

7.  Relational memory and hippocampal function in psychotic bipolar disorder.

Authors:  Suzanne N Avery; Lisa E Williams; Austin A Woolard; Stephan Heckers
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-09-11       Impact factor: 5.270

8.  Abnormal temporal lobe white matter as a biomarker for genetic risk of bipolar disorder.

Authors:  Katie Mahon; Katherine E Burdick; Toshikazu Ikuta; Raphael J Braga; Patricia Gruner; Anil K Malhotra; Philip R Szeszko
Journal:  Biol Psychiatry       Date:  2012-10-01       Impact factor: 13.382

9.  Hippocampal volume is reduced in schizophrenia and schizoaffective disorder but not in psychotic bipolar I disorder demonstrated by both manual tracing and automated parcellation (FreeSurfer).

Authors:  Sara J M Arnold; Elena I Ivleva; Tejas A Gopal; Anil P Reddy; Haekyung Jeon-Slaughter; Carolyn B Sacco; Alan N Francis; Neeraj Tandon; Anup S Bidesi; Bradley Witte; Gaurav Poudyal; Godfrey D Pearlson; John A Sweeney; Brett A Clementz; Matcheri S Keshavan; Carol A Tamminga
Journal:  Schizophr Bull       Date:  2014-02-20       Impact factor: 9.306

10.  Investigation of Heschl's gyrus and planum temporale in patients with schizophrenia and bipolar disorder: a proton magnetic resonance spectroscopy study.

Authors:  M I Atagün; E M Şıkoğlu; S S Can; G Karakaş-Uğurlu; S Ulusoy-Kaymak; A Çayköylü; O Algın; M L Phillips; C M Moore; D Öngür
Journal:  Schizophr Res       Date:  2014-12-03       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.